Cargando…
Optimizing the Timing of Highest Hydrocortisone Dose in Children and Adolescents With 21-Hydroxylase Deficiency
CONTEXT: Hydrocortisone treatment of young patients with 21-hydroxylase deficiency (21OHD) is given thrice daily, but there is debate about the optimal timing of the highest hydrocortisone dose, either mimicking the physiological diurnal rhythm (morning), or optimally suppressing androgen activity (...
Autores principales: | Schröder, Mariska A M, van Herwaarden, Antonius E, Span, Paul N, van den Akker, Erica L T, Bocca, Gianni, Hannema, Sabine E, van der Kamp, Hetty J, de Kort, Sandra W K, Mooij, Christiaan F, Schott, Dina A, Straetemans, Saartje, van Tellingen, Vera, van der Velden, Janiëlle A, Sweep, Fred C G J, Claahsen-van der Grinten, Hedi L |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8947312/ https://www.ncbi.nlm.nih.gov/pubmed/34788830 http://dx.doi.org/10.1210/clinem/dgab826 |
Ejemplares similares
-
Challenges in treatment of patients with non-classic congenital adrenal hyperplasia
por: Adriaansen, Bas P. H., et al.
Publicado: (2022) -
Evaluation of Ex Vivo Adrenocorticotropic Hormone Responsiveness of Human Fetal Testis
por: Schröder, Mariska A M, et al.
Publicado: (2023) -
Production of 11-Oxygenated Androgens by Testicular Adrenal Rest Tumors
por: Schröder, Mariska A M, et al.
Publicado: (2021) -
Production of 11-Oxygenated Androgens by Testicular Adrenal Rest Tumors
por: Schröder, Mariska A M, et al.
Publicado: (2021) -
Novel treatments for congenital adrenal hyperplasia
por: Schröder, Mariska A. M., et al.
Publicado: (2022)